Patent · US Active

Biomarker panel for dose assessment of radiation injury and micro plasma filter

US10571463B2 · kind B2 · utility

0Cited by
3References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 23, 2018
Grant dateFeb 25, 2020
Priority date
Expiry dateJul 23, 2038

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/40
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Materials, systems and methods are provided for qualitative assessment of exposure of a person to ionizing radiation by measuring amounts of the biomarkers, wherein a change compared with corresponding un-irradiated control reference ranges of the biomarkers, provides the assessment, wherein the biomarkers include (i) alpha-1-Antichymotrypsin (ACT), (ii) Fms-related tyrosine kinase 3 ligand (Flt3L), and (iii) one or more additional proteins.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.